93 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
diseases. Agios will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 a.m. PT, and a live webcast … at 42nd Annual J.P. Morgan Healthcare Conference
Agios will webcast its corporate presentation from the 42nd Annual J.P. Morgan Healthcare Conference
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
J.P. Morgan Healthcare Conference Agios Pharmaceuticals Brian Goff, Chief Executive Officer January 10, 2024 Exhibit 99.2
Forward-looking statements … of complications increasing as patients age Poor Quality of Life Adult patients with NTDT may have similar or worse Healthcare Related QoL compared with patients
8-K
5gv0jks41gcww gh
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.1
70la3 v5fzijy
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
rc6pmb w8z71kj
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
67p7f lns3ssuivbh1k6
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
fcpd6agafz5ojm4rh ao
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-99.1
o1vcr 3tm
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
qb6b5s2c5
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
EX-99.1
sxwh52yxyrk
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
EX-99.1
3akuh4wh1 2mv16d
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am